已收盘 10-10 16:00:00 美东时间
-1.200
-0.65%
今日重点评级关注:富国银行:维持Kyverna Therapeutics"超配"评级,目标价从24美元升至27美元;Chardan Capital:维持Oculis Holding"买入"评级,目标价从33美元升至51美元
10-09 10:51
B of A Securities analyst Andrew Obin initiates coverage on SPX Technologies (NYSE:SPXC) with a Neutral rating and announces Price Target of $202.
10-08 19:43
SPX Technologies (NYSE:SPXC) has outperformed the market over the past 10 years...
09-30 22:30
An update from SPX ( ($SPXC) ) is now available. On September 9, 2025, SPX Ente...
09-12 04:53
SPX Technologies's (NYSE:SPXC) short percent of float has fallen 12.86% since i...
09-06 02:00
SPX Technologies, Inc. (NYSE:SPXC) ("SPX") announced today that it intends to offer and sell $500 million of shares of its common stock in an underwritten public offering. In addition, SPX intends to grant the
08-12 04:47
SPX Technologies plans to offer $500 million of common stock, with a $75 million option for underwriters, subject to market conditions. BofA Securities, J.P. Morgan, and Wells Fargo Securities are joint book-running managers. The offering is under an SEC-registered shelf registration statement, with a prospectus supplement to be filed. The final terms and completion are uncertain.
08-11 20:46
Analysts' ratings for SPX Technologies (NYSE:SPXC) over the last quarter vary f...
08-02 02:02
SPX Technologies shares are trading higher after the company reported better-th...
08-01 05:11
SPX Technologies (NYSE:SPXC) raises FY2025 Adj EPS guidance from $6.10-$6.40 to $6.35-$6.65 vs $6.30 analyst estimate. Raises FY2025 sales outlook from $2.200 billion-$2.260 billion to $2.225 billion-$2.275 billion vs
08-01 04:17